by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

NSE Products, Inc. DBA Nu Skin Enterprises, Inc. Warning Letter Details

Warning Letter

NSE Products, Inc. DBA Nu Skin Enterprises, Inc.

NSE Products, Inc. DBA Nu Skin Enterprises, Inc., 75 West Center Street Provo , UT 84601 United States

Issue DateMarch 02, 2026

FEI NumberN/A

Violations3

CountryUnited States

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

Electronic Drug Registration and Listing System (eDRLS)/Violations

NSE Products, Inc. DBA Nu Skin Enterprises, Inc. FDA Warning Letter, March 2, 2026